Advertisement
Entire Site
Articles/Fact Sheets
Ask the Experts
Conference Coverage
BROWSE TOPICS IN HIV TREATMENT:
HIV Treatment: Home Page
Just Diagnosed
HIV Medications
First Steps to Treatment
HIV Drug Resistance
Switching or Stopping Treatment
Third Line/Rescue Treatment
Hepatitis C Coinfection
Women & Pregnancy
HIV Treatment for Children
Side Effects & Health Problems
Research & Experimental Drugs
HIV Treatment in the Developing World
T-1249
Show Archived (Historical) Articles
T-1249 Trial Suspended: Formulation Woes Blamed
(December 2003)
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
T-1249 Retains Potent Short-Term Antiviral Activity in Patients Who Have Failed a Regimen Containing T-20
(September 14, 2003)
In
The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy
, from
The Body PRO
Cool Your Jets: T-1249 Development Slows Down
(January/February 2003)
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors and Antiretroviral History Do Not Affect Virologic Response to T-1249
(December 17, 2001)
In
41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001)
, from
The Body PRO
Fusion Inhibitors
(September/October 1999)
T-20 (Pentafuside) and T-1249.
In
GMHC Treatment Issues
, from
Gay Men's Health Crisis
Advertisement
